Literature DB >> 27815779

Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus.

H Ghasemzadeh-Moghaddam1,2, W van Wamel3, A van Belkum3,4, R A Hamat1, V K Neela5.   

Abstract

The humoral immune response against 43 staphylococcal antigens was compared among hospitalized patients where none of them had any staphylococcal infection on the day of admission with or without nasal Staphylococcus aureus carriage. Fifty-nine carriers and 59 matched non-carriers were studied. The carriers harbored S. aureus of 35 different spa types, including three t037/ST239 methicillin-resistant S. aureus (MRSA) (5.1%). Among the 118 patients, 31 acquired S. aureus during hospitalization. In colonized and non-colonized patients, unique patterns of S. aureus-specific immune responses were observed. The mean fluorescence indices (MFIs) of antibodies against 36/43 (83.7%) antigens were seen to be elevated among carriers. The MFI among carriers with acquisition was significantly higher for staphylococcal superantigen-like protein 5 (SSL5, p = 0.028) when compared to carriers without acquisition. High antibody levels against staphylococcal enterotoxin A (SEA) among carriers illustrate its role as a superantigen in both infection and colonization. We also report a dynamic immune response in S. aureus-carrying patients against the recently reported formyl peptide receptor-like inhibitory (FLIPr)-like protein. In the current study, the dynamics of antibodies against staphylococcal antigens among carrier patients seem quite similar to non-carrier patients. To better understand the dynamic immunogenicity during S. aureus infection and colonization, artificial colonization studies and investigation of the changes in the levels of antibodies against other staphylococcal antigens are recommended.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27815779     DOI: 10.1007/s10096-016-2817-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  45 in total

1.  The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Authors:  K B Kirkland; J P Briggs; S L Trivette; W E Wilkinson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-11       Impact factor: 3.254

2.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins.

Authors:  Jovanka Bestebroer; Kok P M van Kessel; Hafida Azouagh; Annemiek M Walenkamp; Ingrid G J Boer; Roland A Romijn; Jos A G van Strijp; Carla J C de Haas
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

4.  Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock.

Authors:  Olivier Dauwalder; Damien Thomas; Tristan Ferry; Anne-Lise Debard; Cédric Badiou; François Vandenesch; Jerome Etienne; Gerard Lina; Guillaume Monneret
Journal:  J Leukoc Biol       Date:  2006-08-02       Impact factor: 4.962

5.  Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1.

Authors:  R J Williams; J M Ward; B Henderson; S Poole; B P O'Hara; M Wilson; S P Nair
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus.

Authors:  F Martineau; F J Picard; P H Roy; M Ouellette; M G Bergeron
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

7.  Chronic granulomatous disease in adults.

Authors:  J G Liese; V Jendrossek; A Jansson; T Petropoulou; S Kloos; M Gahr; B H Belohradsky
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

8.  Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr).

Authors:  M T Tremaine; D K Brockman; M J Betley
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin.

Authors:  Silva Holtfreter; Kristin Bauer; Damien Thomas; Christine Feig; Vera Lorenz; Katharina Roschack; Erika Friebe; Kathleen Selleng; Sandra Lövenich; Timm Greve; Andreas Greinacher; Brigitte Panzig; Susanne Engelmann; Gérard Lina; Barbara M Bröker
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Reclassification of Staphylococcus aureus nasal carriage types.

Authors:  Alex van Belkum; Nelianne J Verkaik; Corné P de Vogel; Hélène A Boelens; Jeroen Verveer; Jan L Nouwen; Henri A Verbrugh; Heiman F L Wertheim
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

View more
  2 in total

Review 1.  Staphylococcus aureus Host Tropism and Its Implications for Murine Infection Models.

Authors:  Daniel M Mrochen; Liliane M Fernandes de Oliveira; Dina Raafat; Silva Holtfreter
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

Review 2.  Staphylococcal trafficking and infection-from 'nose to gut' and back.

Authors:  Elisa J M Raineri; Dania Altulea; Jan Maarten van Dijl
Journal:  FEMS Microbiol Rev       Date:  2022-01-18       Impact factor: 16.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.